Working… Menu

EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02859077
Recruitment Status : Unknown
Verified August 2016 by Caicun Zhou, Shanghai Pulmonary Hospital, Shanghai, China.
Recruitment status was:  Not yet recruiting
First Posted : August 8, 2016
Last Update Posted : August 9, 2016
Information provided by (Responsible Party):
Caicun Zhou, Shanghai Pulmonary Hospital, Shanghai, China

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : July 2017
Estimated Study Completion Date : July 2018